[{"Assets_0_Q3_USD":121945000.0,"CommonStockSharesOutstanding_0_Q3_shares":20496288.0,"EarningsPerShareBasic_1_Q3_USD":-0.45,"EarningsPerShareBasic_3_Q3_USD":-1.24,"EarningsPerShareDiluted_1_Q3_USD":-0.45,"EarningsPerShareDiluted_3_Q3_USD":-1.24,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-14628000.0,"NetIncomeLoss_1_Q3_USD":-9090000.0,"NetIncomeLoss_3_Q3_USD":-23209000.0,"StockholdersEquity_0_Q3_USD":101355000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":20382000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":18668000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":20382000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":18668000.0,"Ticker":"ANAB","CIK":"1370053","name":"ANAPTYSBIO INC","OfficialName":"AnaptysBio Inc. Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"617648593.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20171107"}]